Price $17.35 |
Market Cap
428.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
18.51
|
P/S
24.1
|
Dividend %
-
|
|
P/CF
34.5
|
P/FCF
216.5
|
Op. Cash Flow
1.8K
|
FCF
0.1
|
|
Op. Margin
7.80%
|
Net Margin
-1.00%
|
ROE
-1.20%
|
ROI
-10.50%
|
|
ROA
-1.10%
|
EPS Growth
95.90%
|
Current Ratio
6.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $16.12 | - | - | 3.74B | Strong Buy |
| Vaxart Inc (VXRT) | $3.19 | - | - | 21.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.14 | - | - | 32M | Strong Buy |
| Procyon Corp (PCYN) | $0.24 | - | - | 2M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.70 | - | - | 96.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
